OakChart

Virtus Biotech Clinical Trials ETF

BBCFinancial·Exchange Traded Fund·USA·NYSE·Nov 12 • 3:59 PM ET

43.14-2.07 (-4.57%)
2026-11-13 13:09 CET
Market cap
-
Revenue, TTM
- USD m
Net income, TTM
- USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-
-
Compare

Price

BBC against its 20, 50 and 200-day averages
Terms2050200
Patternshover a marker to name it
RS 6535.0040.0045.0050.0055.00111K221KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BBCclose 43.1420-day 42.6750-day 45.13200-day 45.7043.1452w high 56.1852-week range, not 6 months

23.2% under the 52-week high of 56.18 on 19 Aug 2026. 52-week low 31.25 on 14 Nov 2025. Last 15 sessions, 11.8% high to low

the line is the 50-bar volume average

Setup. RS line 65
CANSLIM 0 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50% — not on the tape: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Institutional Ownership: Over 50%; Average Volume: Over 200K
VCP 2 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High — not on the tape: Relative Volume: Under 1
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; 200-Day Simple Moving Average: Price above SMA200 — not on the tape: Relative Volume: Over 1.5
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High — not on the tape: Average Volume: Over 500K
Breakout 0 of 4 — fails: 52-Week High/Low: New High; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200 — not on the tape: Relative Volume: Over 2
Growth 0 of 4 — not on the tape: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 0 of 5 — not on the tape: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25; Current Ratio: Over 1
Value 0 of 4 — not on the tape: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 1 of 4 — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50% — not on the tape: Float: Under 100M; Average Volume: Over 500K
Accumulation 1 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200 — not on the tape: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200 — not on the tape: Average Volume: Over 500K

Profile

BBC
52-week range, 48% of the way up
31.2556.18

Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

News

latest 14 of 200
  • What's Going On With Alumis Stock Thursday? (Benzinga)
  • Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? (Zacks)
  • Biotech ETF (BBC) Hits New 52-Week High (Zacks)
  • The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI (Zacks)
  • Best-Performing ETFs of Last Week: Healthcare Rules (Zacks)
  • Best-Performing ETFs of Last Week (Zacks)
  • Biotech ETFs Hovering Around a 52-Week: Here's Why (Zacks)
  • Biotech ETF (BBC) Hits New 52-Week High (Zacks)
  • Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)
  • Trade War or Not, Specific Industry ETFs Are in Sweet Spots (Zacks)
  • The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC (Zacks)
  • Best-Performing ETFs of Last Week (Zacks)
  • Aim To Keep Risk Modest And Quality High (Seeking Alpha)
  • 3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)

Quarterly earnings

actual against estimate

No quarterly earnings.

Annual earnings

No annual earnings.

Estimate revisions

Latest snapshot of each period and type.

No estimate revisions.

Estimate history

No estimate history.

Income statement, annual

No statement data.

Income statement, quarterly

The feed stopped.

No statement data.

Balance sheet, annual

No statement data.

Cash flow, annual

No statement data.

Balance sheet, quarterly

The feed stopped.

No statement data.

Cash flow, quarterly

The feed stopped.

No statement data.

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-30-0.1M-23.41K
2026-10-15-0.1M-20.14K
2026-09-30-0.1M-21.31K
2026-09-15-0.1M-22.73K
2026-08-31-0.1M-22.88K
2026-08-14-0.1M-24.71K
2026-07-31-0.1M-27.03K
2026-07-15-0.1M-27.66K
2026-06-30-0.1M-24.25K
2026-06-15-0.0M-21.97K
2026-05-29-0.1M-22.85K
2026-05-15-0.1M-20.40K
2026-04-30-0.1M-19.92K
2026-04-15-0.1M-19.58K
2026-03-31-0.0M-22.81K
2026-03-13-0.0M-24.27K
2026-02-27-0.0M-27.33K
2026-02-13-0.0M-28.65K
2026-01-30-0.0M-26.88K
2026-01-15-0.0M-26.47K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call37.005.507.300.001.4420.000.000.812-0.1460.017
call38.004.706.300.001.2920.000.000.789-0.1430.018
call39.003.805.400.001.1910.000.000.761-0.1390.020
call40.002.804.503.851.08215.000.000.722-0.1370.021
call41.002.203.600.000.9630.000.000.673-0.1350.023
call42.001.102.850.000.8940.000.000.609-0.1360.024
call43.000.952.250.800.8627.000.000.536-0.1320.025
call44.000.201.750.750.8421.000.000.476-0.1600.025
call45.000.001.400.000.8600.000.000.386-0.1290.024
call46.000.001.200.650.9091.000.000.337-0.1340.023
call47.000.001.100.000.9850.000.000.299-0.1380.022
call48.000.001.000.351.0482.000.000.267-0.1400.021
call49.000.000.950.201.1254.000.000.244-0.1430.020
call50.000.000.950.001.2210.000.000.230-0.1500.019
call51.000.000.950.001.3130.000.000.219-0.1570.019
call52.000.000.950.001.4000.000.000.209-0.1630.018
call53.000.000.950.001.4840.000.000.200-0.1680.018
call54.000.000.950.001.5640.000.000.193-0.1730.017
call55.000.000.950.001.6410.000.000.186-0.1780.017
call56.000.000.950.001.7160.000.000.181-0.1820.017
call57.000.000.950.001.7880.000.000.175-0.1860.016
call58.000.000.950.001.8580.000.000.170-0.1900.016
put37.000.000.950.001.3260.000.00-0.188-0.1430.017
put38.000.001.000.001.2100.000.00-0.211-0.1400.018
put39.000.001.050.001.0900.000.00-0.239-0.1360.020
put40.000.001.151.180.9871.000.00-0.279-0.1350.021
put41.000.001.300.000.9020.000.00-0.326-0.1320.023
put42.000.001.600.000.8580.000.00-0.390-0.1330.024
put43.000.351.850.850.7601.000.00-0.467-0.1290.025
put44.000.703.500.001.2060.000.00-0.524-0.1570.025
put45.001.304.202.711.1651.000.00-0.592-0.1460.025
put46.002.004.000.000.8890.000.00-0.661-0.1310.023
put47.002.906.000.001.4390.000.00-0.693-0.1400.022
put48.003.807.000.001.5620.000.00-0.732-0.1360.021
put49.004.707.900.001.6340.000.00-0.755-0.1390.020
put50.005.707.900.001.2780.000.00-0.769-0.1460.019
put51.006.709.100.001.4730.000.00-0.780-0.1530.019
put52.007.7010.900.001.9450.000.00-0.790-0.1590.018
put53.008.7011.900.002.0400.000.00-0.799-0.1640.018
put54.009.7013.000.002.1770.000.00-0.806-0.1690.017
put55.0010.7014.000.002.2650.000.00-0.813-0.1730.017
put56.0011.7014.400.002.0560.000.00-0.819-0.1780.017
put57.0012.7015.300.002.0820.000.00-0.824-0.1820.016
put58.0013.7016.300.002.1570.000.00-0.829-0.1860.016

Latest SEC filings

0
FiledFormDescriptionPeriodLink
No filings.

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Kera Capital Partners, Inc.10.63%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC7.97%
CITADEL ADVISORS LLC4.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.10%
Militia Capital Management LLC2.46%
Quantinno Capital Management LP2.42%
MORGAN STANLEY1.58%
LPL Financial LLC1.07%
GOLDMAN SACHS GROUP INC0.91%
OSAIC HOLDINGS, INC.0.55%

Funds

Fund% owned
-

OakChart. BBC. Cached 15 minutes. Terms

Some panels did not load: snapshot, ratings, insider, lf.